La maladie de Parkinson en France (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Differential modulation of hepatic cytochrome P‐450 enzymes in rat and syrian hamster by 4′‐trifluoromethyl‐2,3,4,5‐tetrachlorobiphenyl

Identifieur interne : 001442 ( Istex/Corpus ); précédent : 001441; suivant : 001443

Differential modulation of hepatic cytochrome P‐450 enzymes in rat and syrian hamster by 4′‐trifluoromethyl‐2,3,4,5‐tetrachlorobiphenyl

Auteurs : Marie-Hélène Bani ; Marie-Hélène Narbonne ; Morio Fukuhara ; Fusao Ushio ; Larry W. Robertson

Source :

RBID : ISTEX:B008AF1592C7A972C513D27AEAFC4B06293EC1AE

English descriptors

Abstract

The effects of a single injection (40 mg/kg) of 4′‐trifluoromethyl‐2,3,4,5‐tetrachlorobiphenyl (CF3) on hepatic cytochrome P‐450 monooxygenases were assessed in rat and syrian hamster. The CF3 treatment significantly increased the total amount of cytochrome P‐450 in both species. In rats, CF3 treatment caused marked increases in ethoxyresorufin O‐deethylase (EROD), arylhydrocarbon hydroxylase (AHH), and testosterone 7α‐hydroxylase activities but significantly reduced the activities of benzphetamine N‐demethylase (BzND), erythromycin N‐demethylase (ErND), testosterone 6β, 16α, and 16β‐hydroxylases, and formation of androstenedione. Administration of CF3 to hamsters strongly induced the activities of EROD, AHH, BzND, testosterone 15α, and 16α‐hydroxylases, and androstenedione production, whereas ErND, testosterone 6β, and 7α‐hydroxylases were decreased. Administration of CF3 to rats induced the CYP1A family proteins and CYP2A1, while CF3 reduced the level of CYP2B1, and, to a lesser extent, of CYP6β2. In hamsters, CF3 treatment significantly induced the CYP1A2, CYP2A1, CYP2A8, and CYP2B1 isozymes, whereas the CYP6β2 level was decreased. The ability of hepatic microsomes to activate aflatoxin B1 and benzo(a)pyrene was elevated by CF3 treatment in hamsters, while activation of aflatoxin B1 was decreased in microsomes from CF3‐treated rats. These results showed differences in the CF3‐induced pattern of rat and hamster cytochrome P‐450 monooxygenases.

Url:
DOI: 10.1002/jbt.2570090504

Links to Exploration step

ISTEX:B008AF1592C7A972C513D27AEAFC4B06293EC1AE

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Differential modulation of hepatic cytochrome P‐450 enzymes in rat and syrian hamster by 4′‐trifluoromethyl‐2,3,4,5‐tetrachlorobiphenyl</title>
<author>
<name sortKey="Bani, Marie Elene" sort="Bani, Marie Elene" uniqKey="Bani M" first="Marie-Hélène" last="Bani">Marie-Hélène Bani</name>
<affiliation>
<mods:affiliation>Laboratoire de Toxicologie Alimentaire, Université Bordeaux I, 33405 Talence, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Narbonne, Marie Elene" sort="Narbonne, Marie Elene" uniqKey="Narbonne M" first="Marie-Hélène" last="Narbonne">Marie-Hélène Narbonne</name>
<affiliation>
<mods:affiliation>Laboratoire de Toxicologie Alimentaire, Université Bordeaux I, 33405 Talence, France</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Laboratoire de Toxicologie Alimentaire, Université Bordeaux I, Avenue des Facultés, F‐33405 Talence Cédex, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Fukuhara, Morio" sort="Fukuhara, Morio" uniqKey="Fukuhara M" first="Morio" last="Fukuhara">Morio Fukuhara</name>
<affiliation>
<mods:affiliation>Department of Pharmaceutical Sciences, National Institute of Public Health, Minato‐Ku, Tokyo 108, Japan</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Ushio, Fusao" sort="Ushio, Fusao" uniqKey="Ushio F" first="Fusao" last="Ushio">Fusao Ushio</name>
<affiliation>
<mods:affiliation>Department of Nutrition, Tokyo Metropolitan Research Laboratory of Public Health, Shinjuku‐Ku, Tokyo 169, Japan</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Robertson, Larry W" sort="Robertson, Larry W" uniqKey="Robertson L" first="Larry W." last="Robertson">Larry W. Robertson</name>
<affiliation>
<mods:affiliation>Graduate Center for Toxicology, University of Kentucky, Lexington, KY</mods:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:B008AF1592C7A972C513D27AEAFC4B06293EC1AE</idno>
<date when="1994" year="1994">1994</date>
<idno type="doi">10.1002/jbt.2570090504</idno>
<idno type="url">https://api.istex.fr/document/B008AF1592C7A972C513D27AEAFC4B06293EC1AE/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001442</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001442</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Differential modulation of hepatic cytochrome P‐450 enzymes in rat and syrian hamster by 4′‐trifluoromethyl‐2,3,4,5‐tetrachlorobiphenyl</title>
<author>
<name sortKey="Bani, Marie Elene" sort="Bani, Marie Elene" uniqKey="Bani M" first="Marie-Hélène" last="Bani">Marie-Hélène Bani</name>
<affiliation>
<mods:affiliation>Laboratoire de Toxicologie Alimentaire, Université Bordeaux I, 33405 Talence, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Narbonne, Marie Elene" sort="Narbonne, Marie Elene" uniqKey="Narbonne M" first="Marie-Hélène" last="Narbonne">Marie-Hélène Narbonne</name>
<affiliation>
<mods:affiliation>Laboratoire de Toxicologie Alimentaire, Université Bordeaux I, 33405 Talence, France</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Laboratoire de Toxicologie Alimentaire, Université Bordeaux I, Avenue des Facultés, F‐33405 Talence Cédex, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Fukuhara, Morio" sort="Fukuhara, Morio" uniqKey="Fukuhara M" first="Morio" last="Fukuhara">Morio Fukuhara</name>
<affiliation>
<mods:affiliation>Department of Pharmaceutical Sciences, National Institute of Public Health, Minato‐Ku, Tokyo 108, Japan</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Ushio, Fusao" sort="Ushio, Fusao" uniqKey="Ushio F" first="Fusao" last="Ushio">Fusao Ushio</name>
<affiliation>
<mods:affiliation>Department of Nutrition, Tokyo Metropolitan Research Laboratory of Public Health, Shinjuku‐Ku, Tokyo 169, Japan</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Robertson, Larry W" sort="Robertson, Larry W" uniqKey="Robertson L" first="Larry W." last="Robertson">Larry W. Robertson</name>
<affiliation>
<mods:affiliation>Graduate Center for Toxicology, University of Kentucky, Lexington, KY</mods:affiliation>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Journal of Biochemical Toxicology</title>
<title level="j" type="abbrev">J. Biochem. Toxicol.</title>
<idno type="ISSN">0887-2082</idno>
<idno type="eISSN">1522-7146</idno>
<imprint>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Weinheim</pubPlace>
<date type="published" when="1994-10">1994-10</date>
<biblScope unit="volume">9</biblScope>
<biblScope unit="issue">5</biblScope>
<biblScope unit="page" from="241">241</biblScope>
<biblScope unit="page" to="248">248</biblScope>
</imprint>
<idno type="ISSN">0887-2082</idno>
</series>
<idno type="istex">B008AF1592C7A972C513D27AEAFC4B06293EC1AE</idno>
<idno type="DOI">10.1002/jbt.2570090504</idno>
<idno type="ArticleID">JBT2570090504</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0887-2082</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>4′‐Trifluoromethyl‐2,3,4,5‐tetrachlorobiphenyl (CF3)</term>
<term>Cytochrome P‐450</term>
<term>Enzyme Induction</term>
<term>Hamster</term>
<term>Rat</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The effects of a single injection (40 mg/kg) of 4′‐trifluoromethyl‐2,3,4,5‐tetrachlorobiphenyl (CF3) on hepatic cytochrome P‐450 monooxygenases were assessed in rat and syrian hamster. The CF3 treatment significantly increased the total amount of cytochrome P‐450 in both species. In rats, CF3 treatment caused marked increases in ethoxyresorufin O‐deethylase (EROD), arylhydrocarbon hydroxylase (AHH), and testosterone 7α‐hydroxylase activities but significantly reduced the activities of benzphetamine N‐demethylase (BzND), erythromycin N‐demethylase (ErND), testosterone 6β, 16α, and 16β‐hydroxylases, and formation of androstenedione. Administration of CF3 to hamsters strongly induced the activities of EROD, AHH, BzND, testosterone 15α, and 16α‐hydroxylases, and androstenedione production, whereas ErND, testosterone 6β, and 7α‐hydroxylases were decreased. Administration of CF3 to rats induced the CYP1A family proteins and CYP2A1, while CF3 reduced the level of CYP2B1, and, to a lesser extent, of CYP6β2. In hamsters, CF3 treatment significantly induced the CYP1A2, CYP2A1, CYP2A8, and CYP2B1 isozymes, whereas the CYP6β2 level was decreased. The ability of hepatic microsomes to activate aflatoxin B1 and benzo(a)pyrene was elevated by CF3 treatment in hamsters, while activation of aflatoxin B1 was decreased in microsomes from CF3‐treated rats. These results showed differences in the CF3‐induced pattern of rat and hamster cytochrome P‐450 monooxygenases.</div>
</front>
</TEI>
<istex>
<corpusName>wiley</corpusName>
<author>
<json:item>
<name>Marie‐Hélène Bani</name>
<affiliations>
<json:string>Laboratoire de Toxicologie Alimentaire, Université Bordeaux I, 33405 Talence, France</json:string>
</affiliations>
</json:item>
<json:item>
<name>Professor Narbonne</name>
<affiliations>
<json:string>Laboratoire de Toxicologie Alimentaire, Université Bordeaux I, 33405 Talence, France</json:string>
<json:string>Laboratoire de Toxicologie Alimentaire, Université Bordeaux I, Avenue des Facultés, F‐33405 Talence Cédex, France</json:string>
</affiliations>
</json:item>
<json:item>
<name>Morio Fukuhara</name>
<affiliations>
<json:string>Department of Pharmaceutical Sciences, National Institute of Public Health, Minato‐Ku, Tokyo 108, Japan</json:string>
</affiliations>
</json:item>
<json:item>
<name>Fusao Ushio</name>
<affiliations>
<json:string>Department of Nutrition, Tokyo Metropolitan Research Laboratory of Public Health, Shinjuku‐Ku, Tokyo 169, Japan</json:string>
</affiliations>
</json:item>
<json:item>
<name>Larry W. Robertson</name>
<affiliations>
<json:string>Graduate Center for Toxicology, University of Kentucky, Lexington, KY</json:string>
</affiliations>
</json:item>
</author>
<subject>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>4′‐Trifluoromethyl‐2,3,4,5‐tetrachlorobiphenyl (CF3)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Cytochrome P‐450</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Rat</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Hamster</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Enzyme Induction</value>
</json:item>
</subject>
<articleId>
<json:string>JBT2570090504</json:string>
</articleId>
<language>
<json:string>eng</json:string>
</language>
<originalGenre>
<json:string>article</json:string>
</originalGenre>
<abstract>The effects of a single injection (40 mg/kg) of 4′‐trifluoromethyl‐2,3,4,5‐tetrachlorobiphenyl (CF3) on hepatic cytochrome P‐450 monooxygenases were assessed in rat and syrian hamster. The CF3 treatment significantly increased the total amount of cytochrome P‐450 in both species. In rats, CF3 treatment caused marked increases in ethoxyresorufin O‐deethylase (EROD), arylhydrocarbon hydroxylase (AHH), and testosterone 7α‐hydroxylase activities but significantly reduced the activities of benzphetamine N‐demethylase (BzND), erythromycin N‐demethylase (ErND), testosterone 6β, 16α, and 16β‐hydroxylases, and formation of androstenedione. Administration of CF3 to hamsters strongly induced the activities of EROD, AHH, BzND, testosterone 15α, and 16α‐hydroxylases, and androstenedione production, whereas ErND, testosterone 6β, and 7α‐hydroxylases were decreased. Administration of CF3 to rats induced the CYP1A family proteins and CYP2A1, while CF3 reduced the level of CYP2B1, and, to a lesser extent, of CYP6β2. In hamsters, CF3 treatment significantly induced the CYP1A2, CYP2A1, CYP2A8, and CYP2B1 isozymes, whereas the CYP6β2 level was decreased. The ability of hepatic microsomes to activate aflatoxin B1 and benzo(a)pyrene was elevated by CF3 treatment in hamsters, while activation of aflatoxin B1 was decreased in microsomes from CF3‐treated rats. These results showed differences in the CF3‐induced pattern of rat and hamster cytochrome P‐450 monooxygenases.</abstract>
<qualityIndicators>
<score>6.907</score>
<pdfVersion>1.3</pdfVersion>
<pdfPageSize>612 x 792 pts (letter)</pdfPageSize>
<refBibsNative>true</refBibsNative>
<abstractCharCount>1469</abstractCharCount>
<pdfWordCount>4579</pdfWordCount>
<pdfCharCount>30173</pdfCharCount>
<pdfPageCount>8</pdfPageCount>
<abstractWordCount>194</abstractWordCount>
</qualityIndicators>
<title>Differential modulation of hepatic cytochrome P‐450 enzymes in rat and syrian hamster by 4′‐trifluoromethyl‐2,3,4,5‐tetrachlorobiphenyl</title>
<refBibs>
<json:item>
<author>
<json:item>
<name>F. P. Guengerich</name>
</json:item>
<json:item>
<name>G. A. Dannan</name>
</json:item>
<json:item>
<name>S. J. Wright</name>
</json:item>
<json:item>
<name>M. T. Martin</name>
</json:item>
<json:item>
<name>L. S. Kamminsky</name>
</json:item>
</author>
<host>
<volume>21</volume>
<pages>
<last>6030</last>
<first>6019</first>
</pages>
<author></author>
<title>Biochemistry</title>
</host>
<title>Purification and characterization of liver microsomal cytochrome P‐450s. Electrophoretic, spectral, catalytic and immunochemical properties and inducibility of eight isozymes isolated from rats treated with phenobarbital or β‐naphtoflavone</title>
</json:item>
<json:item>
<author>
<json:item>
<name>S. D. Black</name>
</json:item>
<json:item>
<name>M. J. Coon</name>
</json:item>
</author>
<host>
<pages>
<last>216</last>
<first>161</first>
</pages>
<author></author>
<title>Cytochrome P‐450</title>
</host>
<title>Comparative structures of P‐450 cytochromes.</title>
</json:item>
<json:item>
<author>
<json:item>
<name>D. R. Nelson</name>
</json:item>
<json:item>
<name>T. Kamataki</name>
</json:item>
<json:item>
<name>D. J. Waxman</name>
</json:item>
<json:item>
<name>F. P. Guengerich</name>
</json:item>
<json:item>
<name>R. W. Estabrook</name>
</json:item>
<json:item>
<name>R. Feyereisen</name>
</json:item>
<json:item>
<name>F. J. Gonzalez</name>
</json:item>
<json:item>
<name>M. J. Coon</name>
</json:item>
<json:item>
<name>I. C. Gunsalus</name>
</json:item>
<json:item>
<name>O. Gotoh</name>
</json:item>
<json:item>
<name>K. Okuda</name>
</json:item>
<json:item>
<name>D. W. Nebert</name>
</json:item>
</author>
<host>
<volume>12</volume>
<pages>
<last>51</last>
<first>1</first>
</pages>
<author></author>
<title>DNA Cell Biol.</title>
</host>
<title>The P‐450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature</title>
</json:item>
<json:item>
<author>
<json:item>
<name>J. R. Gillette</name>
</json:item>
</author>
<host>
<volume>10</volume>
<pages>
<last>87</last>
<first>59</first>
</pages>
<author></author>
<title>Drug Metab. Rev.</title>
</host>
<title>Effects of induction of cytochrome P‐450 enzymes on the concentration of foreign compounds and their metabolites and on the toxicological effects of these compounds</title>
</json:item>
<json:item>
<author>
<json:item>
<name>A. H. Conney</name>
</json:item>
</author>
<host>
<volume>39</volume>
<pages>
<last>2518</last>
<first>2493</first>
</pages>
<author></author>
<title>Life Sci.</title>
</host>
<title>Induction of microsomal cytochrome P‐450 enzymes: the first Bernard Brodie lecture at Pennsylvania State University</title>
</json:item>
<json:item>
<author>
<json:item>
<name>L. C. Litterst</name>
</json:item>
<json:item>
<name>E. G. Mimnaugh</name>
</json:item>
<json:item>
<name>R. L. Reagan</name>
</json:item>
<json:item>
<name>T. E. Gram</name>
</json:item>
</author>
<host>
<volume>3</volume>
<pages>
<last>265</last>
<first>259</first>
</pages>
<author></author>
<title>Drug Metab. Dispos.</title>
</host>
<title>Comparison of in vitro drug metabolism by lung, liver, and kidney of several common laboratory species</title>
</json:item>
<json:item>
<author>
<json:item>
<name>S. S. Thorgeirsson</name>
</json:item>
<json:item>
<name>S. A. Atlas</name>
</json:item>
<json:item>
<name>A. R. Boobis</name>
</json:item>
<json:item>
<name>J. S. Felton</name>
</json:item>
</author>
<host>
<volume>28</volume>
<pages>
<last>226</last>
<first>217</first>
</pages>
<author></author>
<title>Biochem. Pharmacol.</title>
</host>
<title>Species differences in the substrate specificity of hepatic cytochrome P‐448 from polycylic hydrocarbon‐treated animals</title>
</json:item>
<json:item>
<author>
<json:item>
<name>G. Blaǐch</name>
</json:item>
<json:item>
<name>M. Göttlicher</name>
</json:item>
<json:item>
<name>P. Cikryt</name>
</json:item>
<json:item>
<name>M. Metzler</name>
</json:item>
</author>
<host>
<volume>67</volume>
<pages>
<last>138</last>
<first>129</first>
</pages>
<author></author>
<title>Chem. Biol. Interact.</title>
</host>
<title>Induction of P‐450 isozyme activities in Syrian golden hamster compared to rat liver as probed by the rate of 7‐alkoxyresorufin O‐dealkylation</title>
</json:item>
<json:item>
<author>
<json:item>
<name>C. M. Ardies</name>
</json:item>
<json:item>
<name>J. M. Lasker</name>
</json:item>
<json:item>
<name>C. S. Lieber</name>
</json:item>
</author>
<host>
<volume>36</volume>
<pages>
<last>3619</last>
<first>3613</first>
</pages>
<author></author>
<title>Biochem. Pharmacol.</title>
</host>
<title>Characterization of the cytochrome P‐450 monooxygenase system of hamster liver microsomes. Effects of prior treatment with ethanol and other xenobiotics</title>
</json:item>
<json:item>
<author>
<json:item>
<name>V. J. Wroblewski</name>
</json:item>
<json:item>
<name>J. R. Olson</name>
</json:item>
</author>
<host>
<volume>16</volume>
<pages>
<last>51</last>
<first>43</first>
</pages>
<author></author>
<title>Drug Metab. Dispos.</title>
</host>
<title>Effect of monooxygenase inducers and inhibitors on the metabolism of 2,3,7,8‐tetrachlorodibenzo‐p‐dioxin in the rat and hamster</title>
</json:item>
<json:item>
<author>
<json:item>
<name>S. Safe</name>
</json:item>
</author>
<host>
<volume>13</volume>
<pages>
<last>395</last>
<first>319</first>
</pages>
<author></author>
<title>CRC Crit. Rev. Toxicol.</title>
</host>
<title>Polychlorinated biphenyls (PCBs) and polybrominated biphenyls (PBBs): biochemistry, toxicology and mechanism of action</title>
</json:item>
<json:item>
<author>
<json:item>
<name>E. M. Silberhorn</name>
</json:item>
<json:item>
<name>H. P. Glauert</name>
</json:item>
<json:item>
<name>L. W. Robertson</name>
</json:item>
</author>
<host>
<volume>20</volume>
<pages>
<last>494</last>
<first>439</first>
</pages>
<author></author>
<title>Crit. Rev. Toxicol.</title>
</host>
<title>Carcinogenicity of polyhalogenated biphenyls: PCBs and PBBs</title>
</json:item>
<json:item>
<author>
<json:item>
<name>J. T. Borlakoglu</name>
</json:item>
<json:item>
<name>J. Stegeman</name>
</json:item>
<json:item>
<name>R. R. Dils</name>
</json:item>
</author>
<host>
<volume>99</volume>
<pages>
<last>286</last>
<first>279</first>
</pages>
<author></author>
<title>Comp. Biochem. Phys.</title>
</host>
<title>Induction of hepatic cytochrome P‐450 IA1 in pigeons treated in vivo with Aroclor 1254, a commercial mixture of polychorinated biphenyls (PCBs)</title>
</json:item>
<json:item>
<author>
<json:item>
<name>A. Parkinson</name>
</json:item>
<json:item>
<name>L. W. Robertson</name>
</json:item>
<json:item>
<name>L. Safe</name>
</json:item>
<json:item>
<name>S. Safe</name>
</json:item>
</author>
<host>
<volume>30</volume>
<pages>
<last>280</last>
<first>271</first>
</pages>
<author></author>
<title>Chem. Biol. Interact.</title>
</host>
<title>Polychlorinated biphenyls as inducers of hepatic microsomal enzymes: structure‐activity rules</title>
</json:item>
<json:item>
<author>
<json:item>
<name>M. A. Denomme</name>
</json:item>
<json:item>
<name>S. Bandiera</name>
</json:item>
<json:item>
<name>I. Lambert</name>
</json:item>
<json:item>
<name>L. Copp</name>
</json:item>
<json:item>
<name>L. Safe</name>
</json:item>
<json:item>
<name>S. Safe</name>
</json:item>
</author>
<host>
<volume>32</volume>
<pages>
<last>2962</last>
<first>2955</first>
</pages>
<author></author>
<title>Biochem. Pharmacol.</title>
</host>
<title>Polychlorinated biphenyls as phenobarbitone‐type inducers of microsomal enzymes: structure‐activity relationships for a series of 2,4‐dichloro‐substituted congeners</title>
</json:item>
<json:item>
<author>
<json:item>
<name>A. Parkinson</name>
</json:item>
<json:item>
<name>S. H. Safe</name>
</json:item>
<json:item>
<name>L. W. Robertson</name>
</json:item>
<json:item>
<name>P. E. Thomas</name>
</json:item>
<json:item>
<name>D. E. Ryan</name>
</json:item>
<json:item>
<name>L. M. Reik</name>
</json:item>
<json:item>
<name>W. Levin</name>
</json:item>
</author>
<host>
<volume>258</volume>
<pages>
<last>5976</last>
<first>5967</first>
</pages>
<author></author>
<title>J. Biol. Chem.</title>
</host>
<title>Immunochemical quantitation of cytochrome P‐450 isozymes and epoxide hydrolase in liver microsomes from polychlorinated or polybrominated biphenyl‐treated rats, a study of structure‐activity relationships</title>
</json:item>
<json:item>
<author>
<json:item>
<name>V. Azais</name>
</json:item>
<json:item>
<name>M. Arand</name>
</json:item>
<json:item>
<name>P. Rauch</name>
</json:item>
<json:item>
<name>H. Schramm</name>
</json:item>
<json:item>
<name>P. Bellemand</name>
</json:item>
<json:item>
<name>J. F. Narbonne</name>
</json:item>
<json:item>
<name>F. Oesch</name>
</json:item>
<json:item>
<name>G. Pascal</name>
</json:item>
<json:item>
<name>L. W. Robertson</name>
</json:item>
</author>
<host>
<volume>44</volume>
<pages>
<last>354</last>
<first>341</first>
</pages>
<author></author>
<title>Toxicology</title>
</host>
<title>A time‐course investigation of vitamin A levels and drug metabolism enzyme activities in rats following a single treatment with prototypic polychlorinated biphenyls and DDT</title>
</json:item>
<json:item>
<author>
<json:item>
<name>A. Parkinson</name>
</json:item>
<json:item>
<name>P. E. Thomas</name>
</json:item>
<json:item>
<name>D. E. Ryan</name>
</json:item>
<json:item>
<name>W. Levin</name>
</json:item>
<json:item>
<name>T. Fujita</name>
</json:item>
<json:item>
<name>S. Safe</name>
</json:item>
</author>
<host>
<volume>53</volume>
<pages>
<last>300</last>
<first>289</first>
</pages>
<author></author>
<title>Toxicology</title>
</host>
<title>Induction of rat liver microsomal cytochrome P‐450 isozymes and epoxide hydrolase by a series of 4'‐substituted‐2,3,4,5‐tetrachlorobiphenyls</title>
</json:item>
<json:item>
<author>
<json:item>
<name>F. J. Gonzalez</name>
</json:item>
<json:item>
<name>T. Matsugana</name>
</json:item>
<json:item>
<name>K. Nagata</name>
</json:item>
</author>
<host>
<volume>20</volume>
<pages>
<last>837</last>
<first>827</first>
</pages>
<author></author>
<title>Drug Metab. Rev.</title>
</host>
<title>Structure and regulation of P‐450s in the rat P‐450 IIA gene subfamily</title>
</json:item>
<json:item>
<author>
<json:item>
<name>M. Fukuhara</name>
</json:item>
<json:item>
<name>K. Mizokami</name>
</json:item>
<json:item>
<name>M. Sakaguchi</name>
</json:item>
<json:item>
<name>Y. Niimura</name>
</json:item>
<json:item>
<name>K. Kato</name>
</json:item>
<json:item>
<name>S. Inouye</name>
</json:item>
<json:item>
<name>A. Takanaka</name>
</json:item>
</author>
<host>
<volume>39</volume>
<pages>
<last>469</last>
<first>463</first>
</pages>
<author></author>
<title>Biochem. Pharmacol.</title>
</host>
<title>Aflatoxin B1‐specific cytochrome P‐450 isozyme (P‐450‐AFB) inducible by 3‐methylcholanthrene in golden hamsters</title>
</json:item>
<json:item>
<author>
<json:item>
<name>P. Grolier</name>
</json:item>
<json:item>
<name>P. Cassand</name>
</json:item>
<json:item>
<name>E. Antignac</name>
</json:item>
<json:item>
<name>J. F. Narbonne</name>
</json:item>
<json:item>
<name>R. Albrecht</name>
</json:item>
<json:item>
<name>V. Azai</name>
</json:item>
<json:item>
<name>L. W. Robertson</name>
</json:item>
<json:item>
<name>F. Oesch</name>
</json:item>
</author>
<host>
<volume>211</volume>
<pages>
<last>145</last>
<first>139</first>
</pages>
<author></author>
<title>Mut. Res.</title>
</host>
<title>Effects of prototypic PCBs on benzo(a)pyrene mutagenic activity related to vitamin A intake</title>
</json:item>
<json:item>
<author>
<json:item>
<name>J. F. Narbonne</name>
</json:item>
<json:item>
<name>P. Grolier</name>
</json:item>
<json:item>
<name>R. Albrecht</name>
</json:item>
<json:item>
<name>V. Azais</name>
</json:item>
<json:item>
<name>F. Oesch</name>
</json:item>
<json:item>
<name>L. W. Robertson</name>
</json:item>
</author>
<host>
<volume>60</volume>
<pages>
<last>261</last>
<first>253</first>
</pages>
<author></author>
<title>Toxicology</title>
</host>
<title>A time course investigation of vitamin A level and lipid composition of the liver endoplasmic reticulum in rats following treatment with congeneric polychlorobiphenyls</title>
</json:item>
<json:item>
<host>
<author></author>
<title>J. Chem. Soc.</title>
</host>
</json:item>
<json:item>
<author>
<json:item>
<name>M. Fukuhara</name>
</json:item>
<json:item>
<name>T. Nohmi</name>
</json:item>
<json:item>
<name>K. Mizokami</name>
</json:item>
<json:item>
<name>M. Sunouchi</name>
</json:item>
<json:item>
<name>M. Ishidate</name>
</json:item>
<json:item>
<name>A. Takanaka</name>
</json:item>
</author>
<host>
<volume>106</volume>
<pages>
<last>258</last>
<first>253</first>
</pages>
<author></author>
<title>J. Biochem.</title>
</host>
<title>Characterization of three forms of cytochrome P‐450 inducible by 3‐methylcholanthrene in golden hamster livers with special reference to aflatoxin B1 activation</title>
</json:item>
<json:item>
<author>
<json:item>
<name>O. M. Lowry</name>
</json:item>
<json:item>
<name>J. N. Rosenbrough</name>
</json:item>
<json:item>
<name>A. I. Farr</name>
</json:item>
<json:item>
<name>R. J. Randall</name>
</json:item>
</author>
<host>
<volume>192</volume>
<pages>
<last>275</last>
<first>265</first>
</pages>
<author></author>
<title>J. Biochem.</title>
</host>
<title>Protein measurement with Folin phenol reagent</title>
</json:item>
<json:item>
<author>
<json:item>
<name>T. Omura</name>
</json:item>
<json:item>
<name>R. Sato</name>
</json:item>
</author>
<host>
<volume>239</volume>
<pages>
<last>2385</last>
<first>2379</first>
</pages>
<author></author>
<title>J. Bio. Chem.</title>
</host>
<title>The carbon monoxidebinding pigment of liver microsomes. II: Solubilization, purification and properties</title>
</json:item>
<json:item>
<author>
<json:item>
<name>M. D. Burke</name>
</json:item>
<json:item>
<name>R. T. Mayer</name>
</json:item>
</author>
<host>
<volume>3</volume>
<pages>
<last>253</last>
<first>245</first>
</pages>
<author></author>
<title>Drug Metab. Dispos.</title>
</host>
<title>Inherent specificities of purified cytochromes P‐450 and P‐448 toward biphenyl hydroxylation and ethoxyresorufin deethylation</title>
</json:item>
<json:item>
<author>
<json:item>
<name>A. Aito</name>
</json:item>
</author>
<host>
<volume>85</volume>
<pages>
<last>491</last>
<first>488</first>
</pages>
<author></author>
<title>Anal. Biochem.</title>
</host>
<title>A simple and sensitive assay of 7‐ethoxycoumarin deethylation</title>
</json:item>
<json:item>
<author>
<json:item>
<name>W. Dehnen</name>
</json:item>
<json:item>
<name>R. Tomingas</name>
</json:item>
<json:item>
<name>J. Roos</name>
</json:item>
</author>
<host>
<volume>53</volume>
<pages>
<last>383</last>
<first>373</first>
</pages>
<author></author>
<title>Anal. Biochem.</title>
</host>
<title>A modified method for the assay of benzo(a)pyrene hydroxylase</title>
</json:item>
<json:item>
<author>
<json:item>
<name>A. Y. Lu</name>
</json:item>
<json:item>
<name>H. W. Strobel</name>
</json:item>
<json:item>
<name>M. J. Coon</name>
</json:item>
</author>
<host>
<volume>36</volume>
<pages>
<last>551</last>
<first>545</first>
</pages>
<author></author>
<title>Biochem. Biophys. Res. Commun.</title>
</host>
<title>Hydroxylation of benzphetamine and other drugs by a solubilized form of cytochrome P‐450 from liver microsomes: lipid requirement for drug demethylation</title>
</json:item>
<json:item>
<author>
<json:item>
<name>S. A. Wrighton</name>
</json:item>
<json:item>
<name>E. G. Schuetz</name>
</json:item>
<json:item>
<name>P. B. Watkins</name>
</json:item>
<json:item>
<name>P. Maurel</name>
</json:item>
<json:item>
<name>J. Barwick</name>
</json:item>
<json:item>
<name>B. S. Bailey</name>
</json:item>
<json:item>
<name>H. T. Hartle</name>
</json:item>
<json:item>
<name>B. Young</name>
</json:item>
<json:item>
<name>P. Guzelian</name>
</json:item>
</author>
<host>
<volume>28</volume>
<pages>
<last>321</last>
<first>312</first>
</pages>
<author></author>
<title>Molec. Pharmacol.</title>
</host>
<title>Demonstration in multiple species of inducible hepatic cytochromes P‐450 and their mRNAs related to the glucocorticoid‐inducible cytochrome P‐450 of the rat</title>
</json:item>
<json:item>
<author>
<json:item>
<name>Y. Yamazoe</name>
</json:item>
<json:item>
<name>M. Shimada</name>
</json:item>
<json:item>
<name>N. Muraya</name>
</json:item>
<json:item>
<name>R. Kato</name>
</json:item>
</author>
<host>
<volume>262</volume>
<pages>
<last>7428</last>
<first>7423</first>
</pages>
<author></author>
<title>J. Biol. Chem.</title>
</host>
<title>Suppression of the levels of phenobarbitalinducible rat liver cytochromes P450 by pituitary hormones</title>
</json:item>
<json:item>
<author>
<json:item>
<name>U. K. Laemmli</name>
</json:item>
</author>
<host>
<volume>227</volume>
<pages>
<last>685</last>
<first>680</first>
</pages>
<author></author>
<title>Nature</title>
</host>
<title>Cleavage of structural proteins during the assembly of the head of bacteriophage T4</title>
</json:item>
<json:item>
<author>
<json:item>
<name>T. Yahagi</name>
</json:item>
<json:item>
<name>M. Nagao</name>
</json:item>
<json:item>
<name>T. Matsushima</name>
</json:item>
<json:item>
<name>T. Sugimura</name>
</json:item>
<json:item>
<name>M. Okada</name>
</json:item>
</author>
<host>
<volume>48</volume>
<pages>
<last>130</last>
<first>121</first>
</pages>
<author></author>
<title>Mut. Res.</title>
</host>
<title>Mutagenicities of N‐nitrosamines on Salmonella</title>
</json:item>
<json:item>
<author>
<json:item>
<name>C. Ioannides</name>
</json:item>
<json:item>
<name>D. V. Parke</name>
</json:item>
</author>
<host>
<volume>22</volume>
<pages>
<last>85</last>
<first>1</first>
</pages>
<author></author>
<title>Drug Metab. Rev.</title>
</host>
<title>The cytochrome P‐450 I gene family of microsomal hemoproteins and their role in the metabolic activation of chemicals</title>
</json:item>
<json:item>
<author>
<json:item>
<name>R. A. Lubet</name>
</json:item>
<json:item>
<name>J. L. Syi</name>
</json:item>
<json:item>
<name>J. O. Nelson</name>
</json:item>
<json:item>
<name>R. W. Nims</name>
</json:item>
</author>
<host>
<volume>75</volume>
<pages>
<last>339</last>
<first>325</first>
</pages>
<author></author>
<title>Chem. Biol. Interact.</title>
</host>
<title>Induction of hepatic cytochrome P‐450 mediated alkoxyresorufin O‐dealkylase activities in different species by prototype P‐450 inducers</title>
</json:item>
<json:item>
<author>
<json:item>
<name>N. Koga</name>
</json:item>
<json:item>
<name>N. Ariyoshi</name>
</json:item>
<json:item>
<name>H. Nakashima</name>
</json:item>
<json:item>
<name>H. Yoshimura</name>
</json:item>
</author>
<host>
<volume>107</volume>
<pages>
<last>833</last>
<first>826</first>
</pages>
<author></author>
<title>J. Biochem.</title>
</host>
<title>Purification and characterization of two forms of 2,3,4,7,8‐pentachlorodibenzofurane‐inducible cytochrome P‐450 in hamster liver</title>
</json:item>
<json:item>
<author>
<json:item>
<name>T. S. Lai</name>
</json:item>
<json:item>
<name>J. Y. L. Chiang</name>
</json:item>
</author>
<host>
<volume>283</volume>
<pages>
<last>439</last>
<first>429</first>
</pages>
<author></author>
<title>Arch. Biochem. Biophys.</title>
</host>
<title>Cloning and characterization of two major 3‐methylcholanthrene inducible hamster liver cytochrome P450s</title>
</json:item>
<json:item>
<author>
<json:item>
<name>V. J. Wroblewski</name>
</json:item>
<json:item>
<name>T. Gessner</name>
</json:item>
<json:item>
<name>J. R. Olson</name>
</json:item>
</author>
<host>
<volume>37</volume>
<pages>
<last>1517</last>
<first>1509</first>
</pages>
<author></author>
<title>Biochem. Pharmacol.</title>
</host>
<title>Qualitative and quantitative differences in the induction and inhibition of hepatic benzo(a)pyrene metabolism in the rat and hamster</title>
</json:item>
<json:item>
<host>
<author></author>
<title>W. C. Mennes(1992). Species differences in biotransformation. Ph. D. Thesis, Utrecht.</title>
</host>
</json:item>
<json:item>
<author>
<json:item>
<name>I. G. Robertson</name>
</json:item>
<json:item>
<name>E. Zeiger</name>
</json:item>
<json:item>
<name>J. A. Goldstein</name>
</json:item>
</author>
<host>
<volume>4</volume>
<pages>
<last>96</last>
<first>93</first>
</pages>
<author></author>
<title>Carcinogenesis</title>
</host>
<title>Specificity of rat liver cytochrome P‐450 isozymes in the mutagenic activation of benzo(a)pyrene, aromatic amines and aflatoxin B1</title>
</json:item>
<json:item>
<author>
<json:item>
<name>K. Mizokami</name>
</json:item>
<json:item>
<name>T. Nohmi</name>
</json:item>
<json:item>
<name>M. Fukuhara</name>
</json:item>
<json:item>
<name>A. Takanaka</name>
</json:item>
<json:item>
<name>Y. Omori</name>
</json:item>
</author>
<host>
<volume>139</volume>
<pages>
<last>472</last>
<first>466</first>
</pages>
<author></author>
<title>Biochem. Biophys. Res. Commun.</title>
</host>
<title>Purification and characterization of a form of cytochrome P‐456 with high specificity for aflatoxin B1 from 3‐methylcholanthrene‐treated hamster liver</title>
</json:item>
<json:item>
<author>
<json:item>
<name>A. J. Sonderfan</name>
</json:item>
<json:item>
<name>M. P. Arlotto</name>
</json:item>
<json:item>
<name>D. R. Dutton</name>
</json:item>
<json:item>
<name>S. K. McMillen</name>
</json:item>
<json:item>
<name>A. Parkinson</name>
</json:item>
</author>
<host>
<volume>255</volume>
<pages>
<last>41</last>
<first>27</first>
</pages>
<author></author>
<title>Arch. Biochem. Biophys.</title>
</host>
<title>Regulation of testosterone hydroxylation by rat liver microsomal cytochrome P‐450</title>
</json:item>
<json:item>
<author>
<json:item>
<name>F. G. Gonzalez</name>
</json:item>
<json:item>
<name>T. Matsugana</name>
</json:item>
<json:item>
<name>K. Nagata</name>
</json:item>
</author>
<host>
<volume>20</volume>
<pages>
<last>837</last>
<first>827</first>
</pages>
<author></author>
<title>Drug Metab. Rev.</title>
</host>
<title>Structure and regulation of P‐450s in the rat P450 IIA gene subfamily</title>
</json:item>
<json:item>
<author>
<json:item>
<name>M. P. Arlotto</name>
</json:item>
<json:item>
<name>A. Parkinson</name>
</json:item>
</author>
<host>
<volume>270</volume>
<pages>
<last>471</last>
<first>458</first>
</pages>
<author></author>
<title>Arch. Biochem. Biophys.</title>
</host>
<title>Identification of cytochrome P‐450a (P‐450 IIA1) as the principal testosterone 7α‐hydroxylase in rat liver micro‐somes and its regulation by thyroid hormones</title>
</json:item>
<json:item>
<author>
<json:item>
<name>M. Fukuhara</name>
</json:item>
<json:item>
<name>K. Nagata</name>
</json:item>
<json:item>
<name>K. Mizokami</name>
</json:item>
<json:item>
<name>Y. Yamozoe</name>
</json:item>
<json:item>
<name>A. Tanaka</name>
</json:item>
<json:item>
<name>R. Kato</name>
</json:item>
</author>
<host>
<volume>162</volume>
<pages>
<last>272</last>
<first>265</first>
</pages>
<author></author>
<title>Biochem. Biophys. Res. Commun.</title>
</host>
<title>Complete cDNA sequence of a major 3‐methylcholanthrene‐inducible cytochrome P‐450 isozyme (P‐450AFB) of Syrian hamsters with high activity towards aflatoxin B1</title>
</json:item>
<json:item>
<author>
<json:item>
<name>T. S. Lai</name>
</json:item>
<json:item>
<name>J. Y. L. Chiang</name>
</json:item>
</author>
<host>
<volume>5</volume>
<pages>
<last>153</last>
<first>147</first>
</pages>
<author></author>
<title>J. Biochem. Toxicol.</title>
</host>
<title>Aflatoxin B1 metabolism by 3‐methylcholanthrene‐induced hamster hepatic cytochrome P‐450s</title>
</json:item>
<json:item>
<author>
<json:item>
<name>M. Sunouchi</name>
</json:item>
<json:item>
<name>Y. Ishimi</name>
</json:item>
<json:item>
<name>K. Mizokami</name>
</json:item>
<json:item>
<name>F. Fukuhara</name>
</json:item>
<json:item>
<name>A. Takanaka</name>
</json:item>
<json:item>
<name>F. Hanaoka</name>
</json:item>
<json:item>
<name>M. A. Yamada</name>
</json:item>
</author>
<host>
<volume>153</volume>
<pages>
<last>447</last>
<first>441</first>
</pages>
<author></author>
<title>Biochem. Biophys. Res. Commun.</title>
</host>
<title>Preparation and characterization of monoclonal antibodies against a form of hamster liver cytochrome P‐450 highly specific to aflatoxin B1</title>
</json:item>
<json:item>
<author>
<json:item>
<name>D. J. Waxman</name>
</json:item>
<json:item>
<name>A. Ko</name>
</json:item>
<json:item>
<name>C. Walsh</name>
</json:item>
</author>
<host>
<volume>258</volume>
<pages>
<last>11947</last>
<first>11937</first>
</pages>
<author></author>
<title>J. Biol. Chem.</title>
</host>
<title>Regioselectivity and stereoselectivity of androgen hydroxylations catalyzed by cytochrome P‐450 isozymes purified from phenobarbital‐induced rat liver</title>
</json:item>
<json:item>
<author>
<json:item>
<name>S. A. Wrighton</name>
</json:item>
<json:item>
<name>P. Maurel</name>
</json:item>
<json:item>
<name>E. G. Schuetz</name>
</json:item>
<json:item>
<name>P. B. Watkins</name>
</json:item>
<json:item>
<name>B. Young</name>
</json:item>
<json:item>
<name>P. S. Guzelian</name>
</json:item>
</author>
<host>
<volume>24</volume>
<pages>
<last>2178</last>
<first>2171</first>
</pages>
<author></author>
<title>Biochemisty</title>
</host>
<title>Identification of the cytochrome P‐450 induced by macrolide antibiotics in rat and liver as the glucocorticoid responsive cytochrome P‐450p</title>
</json:item>
<json:item>
<author>
<json:item>
<name>A. W. Wood</name>
</json:item>
<json:item>
<name>D. E. Ryan</name>
</json:item>
<json:item>
<name>P. E. Thomas</name>
</json:item>
<json:item>
<name>W. Levin</name>
</json:item>
</author>
<host>
<volume>258</volume>
<pages>
<last>8847</last>
<first>8839</first>
</pages>
<author></author>
<title>J. Biol. Chem.</title>
</host>
<title>Regio‐ and stereoselective metabolism of two C19 steroids by five highly purified and reconstituted rat hepatic cytochrome P‐450 isozymes</title>
</json:item>
<json:item>
<author>
<json:item>
<name>K. Nagata</name>
</json:item>
<json:item>
<name>F. J. Gonzalez</name>
</json:item>
<json:item>
<name>Y. Yamazoe</name>
</json:item>
<json:item>
<name>R. Kato</name>
</json:item>
</author>
<host>
<volume>107</volume>
<pages>
<last>725</last>
<first>718</first>
</pages>
<author></author>
<title>J. Biochem.</title>
</host>
<title>Purification and characterization of four catalytically active testosterone 6β‐hydroxylase P‐450s from rat liver microsomes: comparison of a novel form with three structurally and functionally related forms</title>
</json:item>
<json:item>
<author>
<json:item>
<name>M. R. Halvorson</name>
</json:item>
<json:item>
<name>S. H. Safe</name>
</json:item>
<json:item>
<name>A. Parkinson</name>
</json:item>
<json:item>
<name>T. D. Phillips</name>
</json:item>
</author>
<host>
<volume>9</volume>
<pages>
<last>2108</last>
<first>2103</first>
</pages>
<author></author>
<title>Carcinogenesis</title>
</host>
<title>Aflatoxin B1 hydroxylation by the pregnenolone‐16α‐carbonitrile‐inducible form of rat liver microsomal cytochrome P‐450</title>
</json:item>
<json:item>
<author>
<json:item>
<name>M. R. Halvorson</name>
</json:item>
<json:item>
<name>D. Greenway</name>
</json:item>
<json:item>
<name>D. Eberhart</name>
</json:item>
<json:item>
<name>K. Fitzgerald</name>
</json:item>
<json:item>
<name>A. Parkinson</name>
</json:item>
</author>
<host>
<volume>277</volume>
<pages>
<last>180</last>
<first>166</first>
</pages>
<author></author>
<title>Arch. Biochem. Biophys.</title>
</host>
<title>Reconstitution of testosterone oxidation by purified rat cytochrome P‐450p (IIIA1)</title>
</json:item>
<json:item>
<author>
<json:item>
<name>E. H. Jansen</name>
</json:item>
<json:item>
<name>P. de Fluiter</name>
</json:item>
</author>
<host>
<volume>580</volume>
<pages>
<last>346</last>
<first>325</first>
</pages>
<author></author>
<title>J. Chrom.</title>
</host>
<title>Detection of the enzymatic activity of cytochrome P‐450 enzymes by high‐performance liquid chromatography</title>
</json:item>
<json:item>
<author>
<json:item>
<name>H. M. Wortelboer</name>
</json:item>
<json:item>
<name>C. Kruif</name>
</json:item>
<json:item>
<name>A. A. J. de Iersel</name>
</json:item>
<json:item>
<name>H. E. van Falke</name>
</json:item>
<json:item>
<name>J. Noordhoek</name>
</json:item>
<json:item>
<name>B. J. Blaauboer</name>
</json:item>
</author>
<host>
<volume>42</volume>
<pages>
<last>390</last>
<first>381</first>
</pages>
<author></author>
<title>Biochem. Pharmacol.</title>
</host>
<title>Comparison of cytochrome P‐450 isozymes profiles in rat liver and hepatocyte cultures: the effects of model inducers on apoproteins and biotransformation activities</title>
</json:item>
<json:item>
<author>
<json:item>
<name>J. Y. Chiang</name>
</json:item>
<json:item>
<name>A. W. Steggles</name>
</json:item>
</author>
<host>
<volume>32</volume>
<pages>
<last>1397</last>
<first>1389</first>
</pages>
<author></author>
<title>Biochem. Pharmacol.</title>
</host>
<title>Identification and partial purification of hamster microsomal cytochrome P‐450 isoenzymes</title>
</json:item>
</refBibs>
<genre>
<json:string>article</json:string>
</genre>
<host>
<volume>9</volume>
<publisherId>
<json:string>JBT</json:string>
</publisherId>
<pages>
<total>8</total>
<last>248</last>
<first>241</first>
</pages>
<issn>
<json:string>0887-2082</json:string>
</issn>
<issue>5</issue>
<subject>
<json:item>
<value>Article</value>
</json:item>
</subject>
<genre>
<json:string>journal</json:string>
</genre>
<language>
<json:string>unknown</json:string>
</language>
<eissn>
<json:string>1522-7146</json:string>
</eissn>
<title>Journal of Biochemical Toxicology</title>
<doi>
<json:string>10.1002/(ISSN)1522-7146</json:string>
</doi>
</host>
<publicationDate>1994</publicationDate>
<copyrightDate>1994</copyrightDate>
<doi>
<json:string>10.1002/jbt.2570090504</json:string>
</doi>
<id>B008AF1592C7A972C513D27AEAFC4B06293EC1AE</id>
<score>0.210209</score>
<fulltext>
<json:item>
<extension>pdf</extension>
<original>true</original>
<mimetype>application/pdf</mimetype>
<uri>https://api.istex.fr/document/B008AF1592C7A972C513D27AEAFC4B06293EC1AE/fulltext/pdf</uri>
</json:item>
<json:item>
<extension>zip</extension>
<original>false</original>
<mimetype>application/zip</mimetype>
<uri>https://api.istex.fr/document/B008AF1592C7A972C513D27AEAFC4B06293EC1AE/fulltext/zip</uri>
</json:item>
<istex:fulltextTEI uri="https://api.istex.fr/document/B008AF1592C7A972C513D27AEAFC4B06293EC1AE/fulltext/tei">
<teiHeader>
<fileDesc>
<titleStmt>
<title level="a" type="main" xml:lang="en">Differential modulation of hepatic cytochrome P‐450 enzymes in rat and syrian hamster by 4′‐trifluoromethyl‐2,3,4,5‐tetrachlorobiphenyl</title>
</titleStmt>
<publicationStmt>
<authority>ISTEX</authority>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Weinheim</pubPlace>
<availability>
<p>Copyright © 1994 Wiley‐Liss, Inc., A Wiley Company</p>
</availability>
<date>1994</date>
</publicationStmt>
<notesStmt>
<note>Ministère de la Recherche et de l'Environnement (France)</note>
<note>Science and technology Agency of Japan (Japan)</note>
<note>NATO Collaborative Research Grant (Belgium)</note>
</notesStmt>
<sourceDesc>
<biblStruct type="inbook">
<analytic>
<title level="a" type="main" xml:lang="en">Differential modulation of hepatic cytochrome P‐450 enzymes in rat and syrian hamster by 4′‐trifluoromethyl‐2,3,4,5‐tetrachlorobiphenyl</title>
<author xml:id="author-1">
<persName>
<forename type="first">Marie‐Hélène</forename>
<surname>Bani</surname>
</persName>
<affiliation>Laboratoire de Toxicologie Alimentaire, Université Bordeaux I, 33405 Talence, France</affiliation>
</author>
<author xml:id="author-2">
<persName>
<surname>Narbonne</surname>
</persName>
<roleName type="degree">Professor</roleName>
<affiliation>Laboratoire de Toxicologie Alimentaire, Université Bordeaux I, 33405 Talence, France</affiliation>
<affiliation>Laboratoire de Toxicologie Alimentaire, Université Bordeaux I, Avenue des Facultés, F‐33405 Talence Cédex, France</affiliation>
</author>
<author xml:id="author-3">
<persName>
<forename type="first">Morio</forename>
<surname>Fukuhara</surname>
</persName>
<affiliation>Department of Pharmaceutical Sciences, National Institute of Public Health, Minato‐Ku, Tokyo 108, Japan</affiliation>
</author>
<author xml:id="author-4">
<persName>
<forename type="first">Fusao</forename>
<surname>Ushio</surname>
</persName>
<affiliation>Department of Nutrition, Tokyo Metropolitan Research Laboratory of Public Health, Shinjuku‐Ku, Tokyo 169, Japan</affiliation>
</author>
<author xml:id="author-5">
<persName>
<forename type="first">Larry W.</forename>
<surname>Robertson</surname>
</persName>
<affiliation>Graduate Center for Toxicology, University of Kentucky, Lexington, KY</affiliation>
</author>
</analytic>
<monogr>
<title level="j">Journal of Biochemical Toxicology</title>
<title level="j" type="abbrev">J. Biochem. Toxicol.</title>
<idno type="pISSN">0887-2082</idno>
<idno type="eISSN">1522-7146</idno>
<idno type="DOI">10.1002/(ISSN)1522-7146</idno>
<imprint>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Weinheim</pubPlace>
<date type="published" when="1994-10"></date>
<biblScope unit="volume">9</biblScope>
<biblScope unit="issue">5</biblScope>
<biblScope unit="page" from="241">241</biblScope>
<biblScope unit="page" to="248">248</biblScope>
</imprint>
</monogr>
<idno type="istex">B008AF1592C7A972C513D27AEAFC4B06293EC1AE</idno>
<idno type="DOI">10.1002/jbt.2570090504</idno>
<idno type="ArticleID">JBT2570090504</idno>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<creation>
<date>1994</date>
</creation>
<langUsage>
<language ident="en">en</language>
</langUsage>
<abstract xml:lang="en">
<p>The effects of a single injection (40 mg/kg) of 4′‐trifluoromethyl‐2,3,4,5‐tetrachlorobiphenyl (CF3) on hepatic cytochrome P‐450 monooxygenases were assessed in rat and syrian hamster. The CF3 treatment significantly increased the total amount of cytochrome P‐450 in both species. In rats, CF3 treatment caused marked increases in ethoxyresorufin O‐deethylase (EROD), arylhydrocarbon hydroxylase (AHH), and testosterone 7α‐hydroxylase activities but significantly reduced the activities of benzphetamine N‐demethylase (BzND), erythromycin N‐demethylase (ErND), testosterone 6β, 16α, and 16β‐hydroxylases, and formation of androstenedione. Administration of CF3 to hamsters strongly induced the activities of EROD, AHH, BzND, testosterone 15α, and 16α‐hydroxylases, and androstenedione production, whereas ErND, testosterone 6β, and 7α‐hydroxylases were decreased. Administration of CF3 to rats induced the CYP1A family proteins and CYP2A1, while CF3 reduced the level of CYP2B1, and, to a lesser extent, of CYP6β2. In hamsters, CF3 treatment significantly induced the CYP1A2, CYP2A1, CYP2A8, and CYP2B1 isozymes, whereas the CYP6β2 level was decreased. The ability of hepatic microsomes to activate aflatoxin B1 and benzo(a)pyrene was elevated by CF3 treatment in hamsters, while activation of aflatoxin B1 was decreased in microsomes from CF3‐treated rats. These results showed differences in the CF3‐induced pattern of rat and hamster cytochrome P‐450 monooxygenases.</p>
</abstract>
<textClass xml:lang="en">
<keywords scheme="keyword">
<list>
<head>keywords</head>
<item>
<term>4′‐Trifluoromethyl‐2,3,4,5‐tetrachlorobiphenyl (CF3)</term>
</item>
<item>
<term>Cytochrome P‐450</term>
</item>
<item>
<term>Rat</term>
</item>
<item>
<term>Hamster</term>
</item>
<item>
<term>Enzyme Induction</term>
</item>
</list>
</keywords>
</textClass>
<textClass>
<keywords scheme="Journal Subject">
<list>
<head>article-category</head>
<item>
<term>Article</term>
</item>
</list>
</keywords>
</textClass>
</profileDesc>
<revisionDesc>
<change when="1994-02-23">Received</change>
<change when="1994-10">Published</change>
</revisionDesc>
</teiHeader>
</istex:fulltextTEI>
<json:item>
<extension>txt</extension>
<original>false</original>
<mimetype>text/plain</mimetype>
<uri>https://api.istex.fr/document/B008AF1592C7A972C513D27AEAFC4B06293EC1AE/fulltext/txt</uri>
</json:item>
</fulltext>
<metadata>
<istex:metadataXml wicri:clean="Wiley, elements deleted: body">
<istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration>
<istex:document>
<component version="2.0" type="serialArticle" xml:lang="en">
<header>
<publicationMeta level="product">
<publisherInfo>
<publisherName>Wiley Subscription Services, Inc., A Wiley Company</publisherName>
<publisherLoc>Weinheim</publisherLoc>
</publisherInfo>
<doi registered="yes">10.1002/(ISSN)1522-7146</doi>
<issn type="print">0887-2082</issn>
<issn type="electronic">1522-7146</issn>
<idGroup>
<id type="product" value="JBT"></id>
</idGroup>
<titleGroup>
<title type="main" xml:lang="en" sort="JOURNAL OF BIOCHEMICAL TOXICOLOGY">Journal of Biochemical Toxicology</title>
<title type="short">J. Biochem. Toxicol.</title>
</titleGroup>
</publicationMeta>
<publicationMeta level="part" position="50">
<doi origin="wiley" registered="yes">10.1002/jbt.v9:5</doi>
<numberingGroup>
<numbering type="journalVolume" number="9">9</numbering>
<numbering type="journalIssue">5</numbering>
</numberingGroup>
<coverDate startDate="1994-10">October 1994</coverDate>
</publicationMeta>
<publicationMeta level="unit" type="article" position="4" status="forIssue">
<doi origin="wiley" registered="yes">10.1002/jbt.2570090504</doi>
<idGroup>
<id type="unit" value="JBT2570090504"></id>
</idGroup>
<countGroup>
<count type="pageTotal" number="8"></count>
</countGroup>
<titleGroup>
<title type="articleCategory">Article</title>
<title type="tocHeading1">Articles</title>
</titleGroup>
<copyright ownership="publisher">Copyright © 1994 Wiley‐Liss, Inc., A Wiley Company</copyright>
<eventGroup>
<event type="manuscriptReceived" date="1994-02-23"></event>
<event type="firstOnline" date="2006-06-09"></event>
<event type="publishedOnlineFinalForm" date="2006-06-09"></event>
<event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:2.3.2 mode:FullText source:HeaderRef result:HeaderRef" date="2010-03-06"></event>
<event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-01-29"></event>
<event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-24"></event>
</eventGroup>
<numberingGroup>
<numbering type="pageFirst">241</numbering>
<numbering type="pageLast">248</numbering>
</numberingGroup>
<correspondenceTo>Laboratoire de Toxicologie Alimentaire, Université Bordeaux I, Avenue des Facultés, F‐33405 Talence Cédex, France</correspondenceTo>
<linkGroup>
<link type="toTypesetVersion" href="file:JBT.JBT2570090504.pdf"></link>
</linkGroup>
</publicationMeta>
<contentMeta>
<countGroup>
<count type="figureTotal" number="2"></count>
<count type="tableTotal" number="2"></count>
<count type="referenceTotal" number="57"></count>
</countGroup>
<titleGroup>
<title type="main" xml:lang="en">Differential modulation of hepatic cytochrome P‐450 enzymes in rat and syrian hamster by 4′‐trifluoromethyl‐2,3,4,5‐tetrachlorobiphenyl</title>
<title type="short" xml:lang="en">(CF3) ON RAT HAMSTER HEPATIC CYTOCHROME P‐450</title>
</titleGroup>
<creators>
<creator xml:id="au1" creatorRole="author" affiliationRef="#af1">
<personName>
<givenNames>Marie‐Hélène</givenNames>
<familyName>Bani</familyName>
</personName>
</creator>
<creator xml:id="au2" creatorRole="author" affiliationRef="#af1" corresponding="yes">
<personName>
<honorifics>Professor</honorifics>
<givenNames>Jean‐Franco̧is</givenNames>
<familyName>Narbonne</familyName>
</personName>
</creator>
<creator xml:id="au3" creatorRole="author" affiliationRef="#af2">
<personName>
<givenNames>Morio</givenNames>
<familyName>Fukuhara</familyName>
</personName>
</creator>
<creator xml:id="au4" creatorRole="author" affiliationRef="#af3">
<personName>
<givenNames>Fusao</givenNames>
<familyName>Ushio</familyName>
</personName>
</creator>
<creator xml:id="au5" creatorRole="author" affiliationRef="#af4">
<personName>
<givenNames>Larry W.</givenNames>
<familyName>Robertson</familyName>
</personName>
</creator>
</creators>
<affiliationGroup>
<affiliation xml:id="af1" countryCode="FR" type="organization">
<unparsedAffiliation>Laboratoire de Toxicologie Alimentaire, Université Bordeaux I, 33405 Talence, France</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af2" countryCode="JP" type="organization">
<unparsedAffiliation>Department of Pharmaceutical Sciences, National Institute of Public Health, Minato‐Ku, Tokyo 108, Japan</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af3" countryCode="JP" type="organization">
<unparsedAffiliation>Department of Nutrition, Tokyo Metropolitan Research Laboratory of Public Health, Shinjuku‐Ku, Tokyo 169, Japan</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af4" countryCode="US" type="organization">
<unparsedAffiliation>Graduate Center for Toxicology, University of Kentucky, Lexington, KY</unparsedAffiliation>
</affiliation>
</affiliationGroup>
<keywordGroup xml:lang="en" type="author">
<keyword xml:id="kwd1">4′‐Trifluoromethyl‐2,3,4,5‐tetrachlorobiphenyl (CF3)</keyword>
<keyword xml:id="kwd2">Cytochrome P‐450</keyword>
<keyword xml:id="kwd3">Rat</keyword>
<keyword xml:id="kwd4">Hamster</keyword>
<keyword xml:id="kwd5">Enzyme Induction</keyword>
</keywordGroup>
<fundingInfo>
<fundingAgency>Ministère de la Recherche et de l'Environnement (France)</fundingAgency>
</fundingInfo>
<fundingInfo>
<fundingAgency>Science and technology Agency of Japan (Japan)</fundingAgency>
</fundingInfo>
<fundingInfo>
<fundingAgency>NATO Collaborative Research Grant (Belgium)</fundingAgency>
</fundingInfo>
<abstractGroup>
<abstract type="main" xml:lang="en">
<title type="main">Abstract</title>
<p>The effects of a single injection (40 mg/kg) of 4′‐trifluoromethyl‐2,3,4,5‐tetrachlorobiphenyl (CF3) on hepatic cytochrome P‐450 monooxygenases were assessed in rat and syrian hamster. The CF3 treatment significantly increased the total amount of cytochrome P‐450 in both species. In rats, CF3 treatment caused marked increases in ethoxyresorufin
<i>O</i>
‐deethylase (EROD), arylhydrocarbon hydroxylase (AHH), and testosterone 7α‐hydroxylase activities but significantly reduced the activities of benzphetamine
<i>N</i>
‐demethylase (BzND), erythromycin
<i>N</i>
‐demethylase (ErND), testosterone 6β, 16α, and 16β‐hydroxylases, and formation of androstenedione. Administration of CF3 to hamsters strongly induced the activities of EROD, AHH, BzND, testosterone 15α, and 16α‐hydroxylases, and androstenedione production, whereas ErND, testosterone 6β, and 7α‐hydroxylases were decreased. Administration of CF3 to rats induced the CYP1A family proteins and CYP2A1, while CF3 reduced the level of CYP2B1, and, to a lesser extent, of CYP6β2. In hamsters, CF3 treatment significantly induced the CYP1A2, CYP2A1, CYP2A8, and CYP2B1 isozymes, whereas the CYP6β2 level was decreased. The ability of hepatic microsomes to activate aflatoxin B1 and benzo(
<i>a</i>
)pyrene was elevated by CF3 treatment in hamsters, while activation of aflatoxin B1 was decreased in microsomes from CF3‐treated rats. These results showed differences in the CF3‐induced pattern of rat and hamster cytochrome P‐450 monooxygenases.</p>
</abstract>
</abstractGroup>
</contentMeta>
</header>
</component>
</istex:document>
</istex:metadataXml>
<mods version="3.6">
<titleInfo lang="en">
<title>Differential modulation of hepatic cytochrome P‐450 enzymes in rat and syrian hamster by 4′‐trifluoromethyl‐2,3,4,5‐tetrachlorobiphenyl</title>
</titleInfo>
<titleInfo type="abbreviated" lang="en">
<title>(CF3) ON RAT HAMSTER HEPATIC CYTOCHROME P‐450</title>
</titleInfo>
<titleInfo type="alternative" contentType="CDATA" lang="en">
<title>Differential modulation of hepatic cytochrome P‐450 enzymes in rat and syrian hamster by 4′‐trifluoromethyl‐2,3,4,5‐tetrachlorobiphenyl</title>
</titleInfo>
<name type="personal">
<namePart type="given">Marie‐Hélène</namePart>
<namePart type="family">Bani</namePart>
<affiliation>Laboratoire de Toxicologie Alimentaire, Université Bordeaux I, 33405 Talence, France</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="termsOfAddress">Professor</namePart>
<namePart type="family">Narbonne</namePart>
<affiliation>Laboratoire de Toxicologie Alimentaire, Université Bordeaux I, 33405 Talence, France</affiliation>
<affiliation>Laboratoire de Toxicologie Alimentaire, Université Bordeaux I, Avenue des Facultés, F‐33405 Talence Cédex, France</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Morio</namePart>
<namePart type="family">Fukuhara</namePart>
<affiliation>Department of Pharmaceutical Sciences, National Institute of Public Health, Minato‐Ku, Tokyo 108, Japan</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Fusao</namePart>
<namePart type="family">Ushio</namePart>
<affiliation>Department of Nutrition, Tokyo Metropolitan Research Laboratory of Public Health, Shinjuku‐Ku, Tokyo 169, Japan</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Larry W.</namePart>
<namePart type="family">Robertson</namePart>
<affiliation>Graduate Center for Toxicology, University of Kentucky, Lexington, KY</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<typeOfResource>text</typeOfResource>
<genre type="article" displayLabel="article"></genre>
<originInfo>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<place>
<placeTerm type="text">Weinheim</placeTerm>
</place>
<dateIssued encoding="w3cdtf">1994-10</dateIssued>
<dateCaptured encoding="w3cdtf">1994-02-23</dateCaptured>
<copyrightDate encoding="w3cdtf">1994</copyrightDate>
</originInfo>
<language>
<languageTerm type="code" authority="rfc3066">en</languageTerm>
<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</language>
<physicalDescription>
<internetMediaType>text/html</internetMediaType>
<extent unit="figures">2</extent>
<extent unit="tables">2</extent>
<extent unit="references">57</extent>
</physicalDescription>
<abstract lang="en">The effects of a single injection (40 mg/kg) of 4′‐trifluoromethyl‐2,3,4,5‐tetrachlorobiphenyl (CF3) on hepatic cytochrome P‐450 monooxygenases were assessed in rat and syrian hamster. The CF3 treatment significantly increased the total amount of cytochrome P‐450 in both species. In rats, CF3 treatment caused marked increases in ethoxyresorufin O‐deethylase (EROD), arylhydrocarbon hydroxylase (AHH), and testosterone 7α‐hydroxylase activities but significantly reduced the activities of benzphetamine N‐demethylase (BzND), erythromycin N‐demethylase (ErND), testosterone 6β, 16α, and 16β‐hydroxylases, and formation of androstenedione. Administration of CF3 to hamsters strongly induced the activities of EROD, AHH, BzND, testosterone 15α, and 16α‐hydroxylases, and androstenedione production, whereas ErND, testosterone 6β, and 7α‐hydroxylases were decreased. Administration of CF3 to rats induced the CYP1A family proteins and CYP2A1, while CF3 reduced the level of CYP2B1, and, to a lesser extent, of CYP6β2. In hamsters, CF3 treatment significantly induced the CYP1A2, CYP2A1, CYP2A8, and CYP2B1 isozymes, whereas the CYP6β2 level was decreased. The ability of hepatic microsomes to activate aflatoxin B1 and benzo(a)pyrene was elevated by CF3 treatment in hamsters, while activation of aflatoxin B1 was decreased in microsomes from CF3‐treated rats. These results showed differences in the CF3‐induced pattern of rat and hamster cytochrome P‐450 monooxygenases.</abstract>
<note type="funding">Ministère de la Recherche et de l'Environnement (France)</note>
<note type="funding">Science and technology Agency of Japan (Japan)</note>
<note type="funding">NATO Collaborative Research Grant (Belgium)</note>
<subject lang="en">
<genre>keywords</genre>
<topic>4′‐Trifluoromethyl‐2,3,4,5‐tetrachlorobiphenyl (CF3)</topic>
<topic>Cytochrome P‐450</topic>
<topic>Rat</topic>
<topic>Hamster</topic>
<topic>Enzyme Induction</topic>
</subject>
<relatedItem type="host">
<titleInfo>
<title>Journal of Biochemical Toxicology</title>
</titleInfo>
<titleInfo type="abbreviated">
<title>J. Biochem. Toxicol.</title>
</titleInfo>
<genre type="journal">journal</genre>
<subject>
<genre>article-category</genre>
<topic>Article</topic>
</subject>
<identifier type="ISSN">0887-2082</identifier>
<identifier type="eISSN">1522-7146</identifier>
<identifier type="DOI">10.1002/(ISSN)1522-7146</identifier>
<identifier type="PublisherID">JBT</identifier>
<part>
<date>1994</date>
<detail type="volume">
<caption>vol.</caption>
<number>9</number>
</detail>
<detail type="issue">
<caption>no.</caption>
<number>5</number>
</detail>
<extent unit="pages">
<start>241</start>
<end>248</end>
<total>8</total>
</extent>
</part>
</relatedItem>
<identifier type="istex">B008AF1592C7A972C513D27AEAFC4B06293EC1AE</identifier>
<identifier type="DOI">10.1002/jbt.2570090504</identifier>
<identifier type="ArticleID">JBT2570090504</identifier>
<accessCondition type="use and reproduction" contentType="copyright">Copyright © 1994 Wiley‐Liss, Inc., A Wiley Company</accessCondition>
<recordInfo>
<recordContentSource>WILEY</recordContentSource>
<recordOrigin>Wiley Subscription Services, Inc., A Wiley Company</recordOrigin>
</recordInfo>
</mods>
</metadata>
<serie></serie>
</istex>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001442 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 001442 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Istex
   |étape=   Corpus
   |type=    RBID
   |clé=     ISTEX:B008AF1592C7A972C513D27AEAFC4B06293EC1AE
   |texte=   Differential modulation of hepatic cytochrome P‐450 enzymes in rat and syrian hamster by 4′‐trifluoromethyl‐2,3,4,5‐tetrachlorobiphenyl
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024